Growth in Bioscience and Pharmaceutical R&D Drives the Market for Gene Expression Reagents, According to a New Trend Report Published by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a trend report on Gene Expression Reagents. Market for Gene Expression Reagents is projected to witness healthy growth led by robust increases in diagnostic tests based on gene expression signatures and patterns.

Gene Expression Reagents: A Trend Report

San Jose, California (PRWEB)January 08, 2014

Follow us on LinkedIn – Gene expression refers to the process of unlocking the genetic code contained in the DNA. Understanding the functioning of genes remains critical towards identifying underlying causes of disease progression. Market for gene expression reagents has been benefiting from developments in biomedical gene expression profiling. As special chemicals developed for use in gene expression studies, gene expression reagents are currently witnessing strong demand in sync with the rise in gene expression tests. Growth in the market is also expected to benefit from the growing use of gene expression tests in diagnosis of thyroid cancer, colon cancer, multiple myeloma, uveal melanoma, and cardiovascular risk assessment.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.